PRESS
POSTED 16 Jul 2020
Veryan Medical announces the completion of subject enrolment into the MIMICS-2 clinical study of its BioMimics 3D® Self-Expanding Stent System. Enrolment in the MIMICS-2 study concluded with a total of 271 patients who were enrolled across 47 investigational sites in Germany, the USA and Japan.
©Veryan Medical 2022
BioMimics 3D Vascular Stent System has FDA and CE Mark approval.
BioMimics 3D & Swirling Flow Stent are registered trademarks of Veryan Medical Limited.
Veryan Medical Limited is a member of the Otsuka Medical Devices group of companies.
CAUTION: Federal law restricts this device to sale by or on the order of a physician.
PAM 14 Version 3.0
